Complementary Oncology Report
Complementary Oncology Report is a source for like-minded practitioners, with a TCM and Complementary Health background, to engage in evidence-based integrative oncology. In our studies in Australia, the US and China, and our meetings with orthodox oncologists, we have found both an increasing acceptance of the idea of integration and an increasing amount of evidence to support these integrative approaches to oncology. This is due to an increasing number of studies on the efficacy of botanical, non-standard interventions and a real need to provide the best treatment for cancer patients.
Latest works
-
The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer
Cervical cancer is a pertinent global health issue as it is the fourth most common cancer in women worldwide and causes more than one quarter of [...]
-
Vitamin E neuroprotection for cisplatin neuropathy. A randomized, placebo-controlled trial.
Pace A, Giannarelli D, Galiè E, et al. Neurology. March 2, 2010 vol. 74 no. 9 762-766. doi: 10.1212/WNL.0b013e3181d5279e Objective: The clinical use of cisplatin chemotherapy [...]
-
Effects of a Chinese medical herbs complex on cellular immunity and toxicity-related conditions of breast cancer patients
Ganoderma Rose Geranium A randomised, double-blind, placebo-controlled study was conducted to examine whether the Chinese medicinal herb complex, called RG-CMH, which represents a mixture of rose [...]
-
Forsythiae Fructus Inhibits B16 Melanoma Growth
Forsythiae Fructus (lianqiao) is one of the most fundamental herbs in traditional Chinese medicine (TCM). It is a typical heat-clearing and detoxicating herb, according to TCM [...]
-
Folic Acid Supplementation Adversely Affects Chemosensitivity of Colon Cancer Cells to 5-fluorouracil
Folic acid (FA) fortification and widespread supplemental use have significantly increased folate status in North America. Furthermore, >50% of colorectal cancer patients use FA supplement. The [...]
